Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.
Chettab K, Fitzsimmons C, Novikov A, Denis M, Phelip C, Mathé D, Choffour PA, Beaumel S, Fourmaux E, Norca P, Kryza D, Evesque A, Jordheim LP, Perrial E, Matera EL, Caroff M, Kerzerho J, Dumontet C. Chettab K, et al. Among authors: beaumel s. Front Immunol. 2023 May 8;14:1066402. doi: 10.3389/fimmu.2023.1066402. eCollection 2023. Front Immunol. 2023. PMID: 37223101 Free PMC article.
Characterization of T-DM1-resistant breast cancer cells.
Sauveur J, Conilh L, Beaumel S, Chettab K, Jordheim LP, Matera EL, Dumontet C. Sauveur J, et al. Among authors: beaumel s. Pharmacol Res Perspect. 2020 Aug;8(4):e00617. doi: 10.1002/prp2.617. Pharmacol Res Perspect. 2020. PMID: 32583565 Free PMC article.
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.
Geneste A, Duong MN, Molina L, Conilh L, Beaumel S, Cleret A, Chettab K, Lachat M, Jordheim LP, Matera EL, Dumontet C. Geneste A, et al. Among authors: beaumel s. BMC Pharmacol Toxicol. 2020 Aug 14;21(1):61. doi: 10.1186/s40360-020-00436-z. BMC Pharmacol Toxicol. 2020. PMID: 32795383 Free PMC article.
Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates.
Viricel W, Fournet G, Beaumel S, Perrial E, Papot S, Dumontet C, Joseph B. Viricel W, et al. Among authors: beaumel s. Chem Sci. 2019 Mar 6;10(14):4048-4053. doi: 10.1039/c9sc00285e. eCollection 2019 Apr 14. Chem Sci. 2019. PMID: 31015945 Free PMC article.
Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice.
Gouez M, Rébillard A, Thomas A, Beaumel S, Matera EL, Gouraud E, Orfila L, Martin B, Pérol O, Chaveroux C, Chirico EN, Dumontet C, Fervers B, Pialoux V. Gouez M, et al. Among authors: beaumel s. Front Immunol. 2024 Feb 15;15:1368550. doi: 10.3389/fimmu.2024.1368550. eCollection 2024. Front Immunol. 2024. PMID: 38426110 Free PMC article.
Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
Bakri FG, Mollin M, Beaumel S, Vigne B, Roux-Buisson N, Al-Wahadneh AM, Alzyoud RM, Hayajneh WA, Daoud AK, Shukair MEA, Karadshe MF, Sarhan MM, Al-Ramahi JAW, Fauré J, Rendu J, Stasia MJ. Bakri FG, et al. Among authors: beaumel s. Front Immunol. 2021 Mar 5;12:639226. doi: 10.3389/fimmu.2021.639226. eCollection 2021. Front Immunol. 2021. PMID: 33746979 Free PMC article.
Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.
Mollin M, Beaumel S, Vigne B, Brault J, Roux-Buisson N, Rendu J, Barlogis V, Catho G, Dumeril C, Fouyssac F, Monnier D, Gandemer V, Revest M, Brion JP, Bost-Bru C, Jeziorski E, Eitenschenck L, Jarrasse C, Drillon Haus S, Houachée-Chardin M, Hancart M, Michel G, Bertrand Y, Plantaz D, Kelecic J, Traberg R, Kainulainen L, Fauré J, Fieschi F, Stasia MJ. Mollin M, et al. Among authors: beaumel s. Clin Exp Immunol. 2021 Feb;203(2):247-266. doi: 10.1111/cei.13520. Epub 2020 Oct 12. Clin Exp Immunol. 2021. PMID: 32954498 Free PMC article.
18 results